MANUEL
PRAGA TERENTE
Profesor emérito
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (21)
2024
-
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis
Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation
Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 222-235
2022
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
Kidney International Reports, Vol. 7, Núm. 4, pp. 831-840
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
2021
-
Consulta monográfica de onconefrología. Justificación y puesta en marcha
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 2, pp. 154-164
-
Pre-emptive rituximab in focal and segmental glomerulosclerosis patients at risk of recurrence after kidney transplantation
Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 139-148
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
2018
-
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
Kidney International, Vol. 93, Núm. 2, pp. 450-459
-
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
Kidney International Reports, Vol. 3, Núm. 1, pp. 122-132
2016
-
Altered underlying renal tubular function in patients with chronic hepatitis B receiving nucleos(t)ide analogs in a real-world setting the MENTE study
Journal of Clinical Gastroenterology, Vol. 50, Núm. 9, pp. 779-789
2015
2013
-
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document
Nefrologia, Vol. 33, Núm. 1, pp. 27-45
-
Compliance with mineral metabolism targets in haemodialysis patients: Moving backwards?
Blood Purification, Vol. 36, Núm. 2, pp. 122-131
2012
-
Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: Results from years 2009-2010
Nefrologia, Vol. 32, Núm. 6, pp. 743-753
2011
-
Chronic renal allograft damage: Existing challenges
Transplantation, Vol. 91, Núm. 9 SUPPL.
2009
-
Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis
Clinical Journal of the American Society of Nephrology, Vol. 4, Núm. 8, pp. 1317-1323
2005
-
Farmacogenética del sistema de la angiotensina en la nefropatía no diabética
Nefrologia, Vol. 25, Núm. 4, pp. 381-386